Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation

Gut

Volumn 41, Issue 6, 1997, Pages 793-800

  Autenrieth, I B ^a   Bucheler, N ^a   Bohn, E ^a   Heinze, G ^a   Horak, I ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bowel inflammation; Cytokine; Interleukin 2 deficient mice; MRNA expression

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTERITIS; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0031451918     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.6.793     Document Type: Article

References (57)

1. MacDermott RP, Stenson WF. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 1988;42:285-328.
2. Podolsky DK, Inflammatory bowel disease (first of two parts). N Engl J Med 1991;325:928-37.
3. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334:841-8.
4. Sartor RB. Cytokines in inflammatory bowel disease. Prog Inflammatory Bowel Dis 1991;12:5-8.
5. Podolsky DK. Inflammatory bowel disease (second of two parts). N Engl J Med 1991;325:1008-16.
6. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106: 1455-66.
7. Casini Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immonol 1995; 154:2434-40.
8. Kusugami K, Matsuura T, West GA, Youngman KR, Rachmilewitz D, Fiocchi C. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology 1991;101:1594-605.
9. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637-42.
10. McCabe RP, Secrist H, Botney M, Egan M, Peters MG. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol 1993;66:52-8.
11. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994;106:960-72.
12. Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102:1620-7.
13. Reinecker HC, Loh KY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995;108:40-50.
14. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, et al. Impaired response of activated phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995;108:21-33.
15. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434-44.
16. Aisenberg J, Ebert EC, Mayer, L. T-cell activation in human intestinal mucosa: the role of superantigens. Gastroetnerology 1993;105:1421-30.
17. Chiodini RJ. Crohn's disease and the mycobacterioses: a review and comparison of two entities. Clin Microbiol Rev 1989;2:90-117.
18. Sanderson JD, Hermon-Taylor J. Mycobacterial diseases of the gut: some impact from molecular biology. Gut 1992;33: 145-7.
19. MacDonald TT. Gastrointestinal inflammation. Inflammatory bowel disease in knockout mice. Curr Biol 1994;4:261-3.
20. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995;3:171-4.
21. Sartor RB. Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis, Inflammatory Bowel Disease (in press).
22. Strober W, Ehrhardt RO. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993;75:203-5.
23. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274-82.
24. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1094;1:553-62.
25. Hollander GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez Ramos JC, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995;3: 27-38.
26. Sadlack B, Kuhn R, Schorle H, Rajewsky K, Muller W, Horak I. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and 4. Eur J Immunol 1994;24:281-4.
27. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
28. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
29. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et al Transforming growth factor beta 1 null mutation in nnice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-4.
30. Shull MM, Ormsby I, Kier AB, Pawlowski S. Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
31. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, et al Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 1995;10:143-50.
32. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brahet P, et al. Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J Clin Immunol 1995;15:101S-5S.
33. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.
34. Smith KA. Interleukin-2. Curr Opin Immunol 1992;4:271-6.
35. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science 1993;262:1059-61.
36. Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 1995;25: 3053-9.
37. Ma A, Datta M, Margosian E, Chen J, Horak I. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 1995;182:1567-72.
38. Simpson SJ, Mizoguchi E, Allen D, Bhan AK, Terhorst C. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618-25.
39. Bohn E, Autenrieth IB. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol 1996;156:1458-68.
40. Bohn E, Heesemann J. Ehlers S. Autenrieth IB. Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica, Infect Immun 1994;62:3027-32.
41. Ehlers S, Mielke MEA, Blankenstein T, Hahn H. Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. J Immunol 1992;149:3016-22.
42. Platzer C, Richter G, Uberla K, Muller W, Blocker H, Diamantstein T, et al. Analysis of cytokine mRNA levels in interleukin 4 transgenic mice by quantitative polymerase chain reaction. Eur J Immunol 1992;22:1179-84.
43. Autenrieth IB, Firsching R. Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study. J Med Microbiol 1996;44:285-94.
44. Autenrieth IB, Hantschmann P, Heymer B, Heesemann J. Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes. Immunobiology 1993;187:1-16.
45. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction RT-PCR). Clin Exp Immunol 1995;101:28-35
46. Sher ME, D'Angelo AJ, Stein TA, Bailey B, Burns G, Wise L. Cytokines in Crohn's colitis. Am J Surg 1995;169:133-6.
47. Fukushima K, West G, Fiocchi C. Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine. Dig Dis Sci 1995;40:1498-505.
48. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-90.
49. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-52.
50. Hunt JS, Chen HL, Hu XL, Chen TY, Morrison DC. Tumor necrosis factor-alpha gene expression in tissues of normal mice. Cytokine 1992;4:340-6.
51. Keshav S, Lawson L, Chung LP, Stein M, Perry VH, Gordon S. Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med 1990;171:327-32.
52. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996;183:2605-16.
53. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4 T cells. J Exp Med 1996;183:2669-74.
54. Ciacci C, Mahida YR, Dignass A, koizumi I, Podolsky DK. Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 1993;92:527-32.
55. Taheri A, Lavagna C, Rampal P. Effect of interleukin 2 on the proliferation of two intestinal cell lines and on the expression of TGF-beta gene and JUN FOS oncogenes. Gastroenterol Clin Biol 1993;17:925-31.
56. Ehrhardt RO, Ludviksson BR, Gray B, Neurath MF, Strober S. Induction and prevention of colonie inflammatoion in IL-2 deficient mice. J Immunol 1997;158:566-73.
57. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.